Vimarsana
Biggest News Aggregation in the World

Design Enabling Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Design Enabling Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Design Enabling Access Today - Breaking & Trending Today

Join The AI Revolution: Transforming Patient Care At Your Fingertips - Vimarsana News

Join The AI Revolution: Transforming Patient Care At Your Fingertips

As we strive for global health equity, innovation, particularly in medical technology, therapeutics and AI, becomes paramount.

Source: forbes.com
Chris Bowen says other countries struck deals for a billion doses of the Pfizer vaccine before Australia signed its agreement. Is he correct? - Vimarsana News

Chris Bowen says other countries struck deals for a billion doses of the Pfizer vaccine before Australia signed its agreement. Is he correct?

Chris Bowen says other countries struck deals for a billion doses of the Pfizer vaccine before Australia signed its agreement. Is he correct? RMIT ABC Fact Check WedWednesday 10 updated WedWednesday 10 MarMarch 2021 at 10:36pm Former opposition spokesman for health Chris Bowen says a billion doses of Pfizer's COVID-19 vaccine were accounted for around the world before the Government made a deal with the company in November. ( Share Print text only The claim The first doses of Australia's COVID-19 vaccination program have at last been administered, but concerns have been expressed that the rol...

Source: abc.net.au
While First COVID-19 Vaccines Arrive, Much of the World Will Have to Wait - Vimarsana News

While First COVID-19 Vaccines Arrive, Much of the World Will Have to Wait

Print this page While the first shots against COVID-19 are rolling out in the United States, Britain and Canada, nearly a quarter of the world's population likely will not have access to a vaccine until at least 2022, according to a new study.  Even in a best-case scenario, the world does not have the manufacturing capacity to cover the entire global population.   Wealthier countries made deals to buy the bulk of vaccine doses before the shots have even finished testing or received regulatory approval.   Meanwhile, a partnership aimed at securing vaccines for low- and middle-income c...